BioMarin Pharmaceuticals
BMRN
BMRN
551 hedge funds and large institutions have $12.7B invested in BioMarin Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 86 funds opening new positions, 198 increasing their positions, 196 reducing their positions, and 86 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
2.56% less ownership
Funds ownership: 97.3% → 94.73% (-2.6%)
17% less capital invested
Capital invested by funds: $15.2B → $12.7B (-$2.54B)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
551
Holding in Top 10
4
Calls
$152M
Puts
$112M
Top Buyers
| 1 | +$225M | |
| 2 | +$95.4M | |
| 3 | +$67.1M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$54M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$45.4M |
Top Sellers
| 1 | -$211M | |
| 2 | -$90.6M | |
| 3 | -$69.4M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$68M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
-$62.2M |